protein-silencing drugs (Avilomics) (Avila/Sanofi)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameprotein-silencing drugs (Avilomics) (Avila/Sanofi)
Drug Alias Nameprotein-silencing drugs (Avilomics) (Avila/Sanofi-Aventis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvila Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvila Therapeutics, IncSanofiCelgene Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A